Article Versions Notes

Prouteau A, Mottier S, Primot A, Cadieu E, Bachelot L, Botherel N, Cabillic F, Houel A, Cornevin L, Kergal C, et al. Canine Oral Melanoma Genomic and Transcriptomic Study Defines Two Molecular Subgroups with Different Therapeutical Targets. Cancers. 2022; 14(2):276. https://doi.org/10.3390/cancers14020276

Prouteau, Anais, Stephanie Mottier, Aline Primot, Edouard Cadieu, Laura Bachelot, Nadine Botherel, Florian Cabillic, Armel Houel, Laurence Cornevin, Camille Kergal, and et al. 2022. "Canine Oral Melanoma Genomic and Transcriptomic Study Defines Two Molecular Subgroups with Different Therapeutical Targets" Cancers 14, no. 2: 276. https://doi.org/10.3390/cancers14020276

Prouteau, A., Mottier, S., Primot, A., Cadieu, E., Bachelot, L., Botherel, N., Cabillic, F., Houel, A., Cornevin, L., Kergal, C., Corre, S., Abadie, J., Hitte, C., Gilot, D., Lindblad-Toh, K., André, C., Derrien, T., & Hedan, B. (2022). Canine Oral Melanoma Genomic and Transcriptomic Study Defines Two Molecular Subgroups with Different Therapeutical Targets. Cancers, 14(2), 276. https://doi.org/10.3390/cancers14020276